AbbVie To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Monday
Portfolio Pulse from Lisa Levin
Top Wall Street analysts have updated their outlooks on several stocks. Barclays increased AbbVie Inc.'s price target from $160 to $170 and upgraded the stock from Equal-Weight to Overweight. JP Morgan cut Olin Corporation's price target from $75 to $48 and downgraded the stock from Overweight to Neutral. UBS increased East West Bancorp, Inc.'s price target from $57 to $61 and upgraded the stock from Neutral to Buy. Other companies mentioned include Chevron Corporation, Eastman Chemical Company, NorthWestern Energy Group, Inc., Datadog, Inc., Balchem Corporation, CubeSmart, and Axos Financial, Inc.
October 30, 2023 | 11:49 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan cut Olin Corporation's price target from $75 to $48 and downgraded the stock from Overweight to Neutral.
The decrease in price target and downgrade in rating by JP Morgan indicates a negative outlook for Olin Corporation, which could lead to a drop in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Barclays increased AbbVie Inc.'s price target from $160 to $170 and upgraded the stock from Equal-Weight to Overweight.
The increase in price target and upgrade in rating by Barclays indicates a positive outlook for AbbVie Inc., which could lead to a rise in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
UBS increased East West Bancorp, Inc.'s price target from $57 to $61 and upgraded the stock from Neutral to Buy.
The increase in price target and upgrade in rating by UBS indicates a positive outlook for East West Bancorp, Inc., which could lead to a rise in its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100